Accumulating lines of evidence suggests that the improper activation of signal transduction pathways (e.g. PI3K/AKT, Hedgehog, STAT3) are critical events in pathologies of T-cell lymphomas [2, 3]. The gene discussed is STAT3; the disease is T-cell non-Hodgkin lymphoma.